Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TETRACYCLIC COMPOUND USED AS CDC7 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2021/032170
Kind Code:
A1
Abstract:
A tetracyclic compound as a Cdc7 inhibitor. Specifically disclosed is a compound represented by formula (I), an isomer thereof, or a pharmaceutically acceptable salt thereof. (I)

Inventors:
LU LUN (CN)
LI GANG (CN)
HU LIHONG (CN)
DING CHARLES Z (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2020/110305
Publication Date:
February 25, 2021
Filing Date:
August 20, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D493/14; A61K31/519; A61K31/5377; A61P35/00; C07D487/22; C07D491/22; C07D493/22
Domestic Patent References:
WO2007068728A22007-06-21
Foreign References:
CN102844320B2016-03-23
CN1989131A2007-06-27
US20090030196A12009-01-29
CN201910769786A2019-08-20
Other References:
E. VANOTTI ET AL.: "Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potential Antitumor Agents. 1. Synthesis and Structure-Activity Relationships", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 51, no. 3, 14 February 2008 (2008-02-14), US, pages 487 - 501, XP002584693, ISSN: 0022-2623, DOI: 10.1021/JM700956R
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: